Protein Discovery and New Objective have entered into a strategic co-marketing and development agreement designed to enable and expand key applications for intact protein analysis using mass spectrometry (top down proteomics).
Reportedly, the companies plan to co-market their respective product lines focused on sample to spray, which include Protein Discovery’s Gelfree 8100 Fractionation System for molecular weight-based fractionation of intact proteins and New Objective’s PicoFrit nanobore chromatography columns and Digital PicoView nanospray sources. Together, this platform enables the production of the most comprehensive top down data available.
The firms intend to co-market their products through industry publications and at selected trade shows, and collaborate on the development of new products that improve the data quality and throughput of intact protein analysis using mass spectrometry.
Chuck Witkowski, president and CEO of Protein Discovery, said: While MS systems have become increasingly capable of analysing intact proteins, achieving a fast, high-quality sample preparation workflow to make productive use of these powerful systems has been challenging for many labs. This new workflow makes top down proteomics research much more practical for a variety of applications, including the characterization of biotherapeutics by mass spectrometry.
Gary Valaskovic, president and CEO of New Objective, said: High quality analysis of intact proteins using mass spectrometry requires highly specialised tools. Protein Discovery’s Gelfree 8100 system permits the reproducible fractionation of intact proteins in a multiplexed fashion, with very high loading capacity and recovery. Coupled with our high performance nanobore chromatography columns and industry-leading nanoelectrospray sources, we believe this platform enables previously unattainable sensitivity and throughput. We intend to continue to work together to optimize and expand the platform for specific applications.